123 EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL

Autor:	Isabelle Rosa, Ariane Mallat, Philippe Mathurin, Dominique Larrey, Magali Bouvier-Alias, Albert Tran, Vincent Leroy, Jean-Pierre Bronowicki, A. Nani, Laurent Alric, V. Dhalluin-Venier, P. Couzigou, M. Charaf-Eddine, Juliette Foucher, Christophe Hézode, J.-M. Pawlotsky, S. Rouanet
Rok vydání:	2009
Předmět:	Oncology medicine.medical_specialty Hepatology business.industry Ribavirin Interim analysis Regimen Non responders Pegylated interferon alfa-2a chemistry.chemical_compound chemistry Hcv genotype 1 Internal medicine medicine business
Zdroj:	Journal of Hepatology. 50:S50
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(09)60125-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c4a954259cad2936868aa028937470f0 https://doi.org/10.1016/s0168-8278(09)60125-2 Full Text from ScienceDirect